Talcum Powder Claimants get Favorable Ruling from Judge

Johnson & Johnson to Pay $700 Million to Settle Talc Investigation

January 8, 2024 — In a major development, Johnson & Johnson (J&J) has tentatively agreed to pay approximately $700 million to resolve an investigation conducted by more than 40 US states. The investigation looked into claims that J&J wrongfully marketed its talc-based baby powder without warning consumers about potential health risks. The settlement aims to avert potential lawsuits alleging that J&J concealed any links between talc and various cancers. This agreement comes after two failed attempts by J&J to impose a settlement on former users through bankruptcy courts.

The Background

J&J, headquartered in New Brunswick, New Jersey, has faced a decade-long litigation over allegations of concealing health risks associated with its talc-based powders. The company’s stock price has been impacted significantly due to the ongoing litigation and the prospect of potential future cancer suits. As part of its strategy to address the mounting legal challenges, J&J had previously offered a $9 billion settlement to resolve all current and future claims related to its baby powder.

Settlement Details

The recent settlement of approximately $700 million is a significant step towards resolving the claims against J&J. The specific terms of the agreement are still being negotiated between J&J and representatives for the state attorneys general. However, both parties have reached an agreement on the approximate total amount. This settlement is separate from the lawsuits filed by the states of Mississippi and New Mexico, which are seeking higher settlements as they have already initiated litigation.

Legal Exposure and Allegations

J&J faces legal exposure beyond the claims made by the states involved in the settlement. The company is confronted with over 50,000 lawsuits alleging that its talc-based powders, including baby powder, contained asbestos and posed a cancer risk. While the majority of these claims relate to ovarian cancer, some also involve mesothelioma, a cancer associated with asbestos exposure. J&J maintains that its talc-based products do not cause cancer and that it has marketed its baby powder responsibly for more than a century.

Impact on Stock Price

The ongoing litigation and the potential financial impact from settlements have affected J&J’s stock price. Following news of the settlement, J&J’s shares experienced a slight decline in trading. The resolution of the talc investigation and subsequent settlements may help alleviate some of the uncertainties surrounding the company, potentially leading to a positive impact on its stock price.

State Lawsuits and Investigation

While only Mississippi and New Mexico have filed lawsuits against J&J over the marketing of its talcum powder, a joint investigation was launched by 42 states and the District of Columbia. Attorneys general from several states, including Arizona and North Carolina, have demanded information from J&J regarding its marketing practices. The settlement agreement being negotiated does not cover the ongoing lawsuits filed by Mississippi and New Mexico, which are pursuing higher settlements as they have already initiated litigation.

Future Outlook

The settlement reached by J&J to resolve the talc investigation is a significant development in the ongoing legal challenges faced by the company. While it marks progress in addressing the allegations of concealing health risks, J&J still faces numerous lawsuits related to its talc-based powders. The outcome of these lawsuits will determine the long-term impact on the company and its reputation. J&J continues to maintain its stance that its talc-based products are safe and do not cause cancer.

Conclusion

Johnson & Johnson’s agreement to pay approximately $700 million to settle the talc investigation by more than 40 US states is a significant step towards resolving the legal challenges the company has faced. The settlement aims to address allegations that J&J wrongfully marketed its talc-based baby powder without warning consumers about potential health risks. While this settlement is a positive development for J&J, the company still faces numerous lawsuits related to its talc-based powders. The outcome of these lawsuits will shape the future of the company and its reputation in the healthcare industry.

Disclaimer: This article is for informational purposes only and should not be considered as legal or financial advice. Readers are encouraged to consult with appropriate professionals for guidance on their specific circumstances.

Table 1: Settlement Details

Settlement Amount	Approx. $700 million
Lawsuits Covered	Multiple states
Allegations	Wrongful marketing, failure to warn about health risks
Ongoing Lawsuits	Mississippi, New Mexico
Legal Exposure	Over 50,000 claims related to talc-based powders

---

UPDATE: JULY 26, 2020.  A judge recently ruled that her court would not hear new Talcum Powder Cancer claims citing jurisdictional conflicts. Now the cases will be tried in Federal Civil Court, which may be generally viewed as a more plaintiff-favorable venue. Since 1971, more than 20 studies have linked talc to cancer, and now Johnson & Johnson faces more than 16,000 lawsuits from Cancer victims who claim talc usage contributed to their Cancer diagnoses.

Contact the Schmidt National Law Group today for a free case evaluation by calling 1-800-631-5656 or use the form at the bottom of this article.

Talc lawsuit claims and settlements page updated on January 8, 2024.

Sources:

“An Empirical Examination of Attorneys’ Choice of Forum in Class Action Litigation,” Thomas E. Willging & Shannon R. Wheatman; Federal Judicial Center. 2005. https://www.uscourts.gov/sites/default/files/clact05.pdf

https://finance.yahoo.com/news/talcum-powder-lawsuit-172700363.html